Financial Daily from THE HINDU group of publications
Saturday, Sep 17, 2005
News
Features
Stocks
Port Info
Archives
Google

Group Sites

 Marketing - Channels and Franchises


Elder Pharma to make Swiss co's arthritis drug

Our Bureau

Mumbai , Sept 16

ELDER Pharmaceuticals will manufacture and market in India Artrodar, an arthritis drug, belonging to Switzerland's TRB Chemedica International SA.

This in-licensing pact marks Elder Pharma's foray into the estimated Rs 800-crore domestic pain segment, besides also scripting TRB Chemedica's entry into India. The drug has a global sales of $200 million, according to an industry representative.

Elder Pharma is an estimated Rs 300-crore company. According to Elder's top brass, the new drug is expected to generate about Rs 20 crore in its third year from launch.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Tata Safari Dicor

Stories in this Section
Youth magazine JAM to reach more cities

Red FM tunes into `common man'
Café Coffee Day goes wi-fi to take orders
TRAI `no' to misleading tariff plans — `Operators must come clean on zero rentals'
Elder Pharma to make Swiss co's arthritis drug
High fashion retail debates ways to sustain profits
Flemingo to set up duty-free shops in African countries
Fabindia plans more outlets in South
ONGC plans more retail prototypes
Tata Coffee plans tie-up with Uganda for new brand
Bid to fill Gap in fashion needs of 35-plus women
Philips Electronics launches new CT scanner in Pune
Philips unveils `ultra fast cardiac CT scanner' in AP hospital

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line